For example, cognitive impairment in in a murine model of schizophrenia was associated with the reversal potential of GABAA currents in pyramidal neurons of the infralimbic prefrontal cortex that resulted from an increased expression of NKCC1, which could be improved by bumetanide [43]. The gene discussed is SLC12A2; the disease is schizophrenia.